BUY Divi's Laboratories Limited — Gaurav Sharma, Globe Capital Market
byGaurav Sharma, Globe Capital MarketHorizon: 1–3 months14 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active swing BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·29 Jul · today
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%
NewsGoogle News·27 Jul · yesterday
Divi's Laboratories begins commercial operations at Unit III greenfield project in Kakinada
NewsGoogle News·25 Jul · 3d ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·21 Jul · 1w ago
1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced
NewsGoogle News·14 Jul · 2w ago
Divis Labs: ₹30 டிவிடெண்ட்! இந்த தேதியை தவறவிடாதீர்கள்!
NewsGoogle News·23 Jul · 5d ago
Divis Labs Ex-Dividend Date July 24: What Investors Should Know
NewsGoogle News·23 Jul · 5d ago
Divis Labs Share Price: રોકાણકારો માટે મહત્વના સમાચાર! ₹30 ડિવિડન્ડ માટે Ex-Dividend Date જાહેર
NewsGoogle News·23 Jul · 5d ago
Divis Laboratories reduces carbon footprint in FY 2025-26
NewsGoogle News·15 Jul · 2w ago
Divis Laboratories fixes July 24 record date for ₹30 dividend
NewsGoogle News·15 Jul · 2w ago
2 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·9 Nov · 9mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Ashish Bahety, Profitmart Securities22 Oct 2026 · Same day · target ₹9,350 · SL hit
- SELL — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹8,750 · SL hit
- SELL — Mehul Kothari, Anand Rathi14 Oct 2026 · ~2 weeks · target ₹8,400 · Active
- BUY — Kavita Jain, Arihant Capital Markets6 Oct 2026 · Next day · target ₹9,750 · Expired
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
More from Gaurav Sharma, Globe Capital Market
- BUY Allied Blenders and Distillers15 Oct 2026 · ~2 weeks · target ₹770 · SL hit
- BUY Angel One13 Oct 2026 · ~2 weeks · target ₹315 · Target hit
- BUY Tata Consultancy Services9 Oct 2026 · ~3 months · target ₹2,240 · Target hit
- BUY PNB Housing Finance9 Oct 2026 · ~2 weeks · target ₹1,210 · Target hit
- SELL Dr. Reddy's Laboratories9 Oct 2026 · ~2 weeks · target ₹1,120 · SL hit

